Citius Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/07/2025 | 166.39 K | $206.32 K | 107.72% | 1.51% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 119.77 K | $148.54 K | 57.40% | 1.09% |
| CITADEL ADVISORS LLC | 11/14/2025 | 92.30 K | $114.45 K | 157.82% | 0.84% |
| BLACKROCK, INC. | 11/12/2025 | 69.85 K | $86.62 K | 0.00% | 0.63% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 48.19 K | $59.75 K | 239.36% | 0.44% |
| NORTHERN TRUST CORP | 11/14/2025 | 27.03 K | $33.51 K | 88.03% | 0.25% |
| UBS GROUP AG | 11/13/2025 | 25.91 K | $32.13 K | -86.57% | 0.24% |
| NEWEDGE ADVISORS, LLC | 11/17/2025 | 25.40 K | $31.50 K | 1.60% | 0.23% |
| STATE STREET CORP | 11/14/2025 | 23.27 K | $28.86 K | 0.00% | 0.21% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 22.80 K | $28.27 K | 71.43% | 0.21% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 21.80 K | $27.04 K | 69.36% | 0.20% |
| ARKADIOS WEALTH ADVISORS | 10/29/2025 | 20.00 K | $24.80 K | 0.00% | 0.18% |
| JANE STREET GROUP, LLC | 11/14/2025 | 18.89 K | $23.42 K | 100.00% | 0.17% |
| XTX TOPCO LTD | 11/14/2025 | 15.92 K | $19.74 K | -20.97% | 0.14% |
| CITADEL ADVISORS LLC | 11/14/2025 | 10.90 K | $13.52 K | -57.59% | 0.10% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 11/12/2025 | 10.04 K | $12.00 K | -94.53% | 0.09% |
| SIMPLEX TRADING, LLC | 11/12/2025 | 9.56 K | $11.00 K | 100.00% | 0.09% |
| IFP ADVISORS, INC | 12/02/2025 | 7.08 K | $8.78 K | 0.00% | 0.06% |
| CHELSEA COUNSEL CO | 11/25/2025 | 4.63 K | $5.74 K | 0.00% | 0.04% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 4.02 K | $4.99 K | 0.05% | 0.04% |
| CITIGROUP INC | 11/10/2025 | 1.62 K | $2.01 K | 100.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 1.49 K | $1.98 K | -11.86% | 0.01% |
| LEGACY WEALTH MANAGMENT, LLC/ID | 11/12/2025 | 930 | $1.15 K | 100.00% | 0.01% |
| LUMINIST CAPITAL LLC | 11/14/2025 | 435 | $596 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 422 | $523 | 11.94% | 0.00% |
| MORGAN STANLEY | 11/14/2025 | 407 | $504 | 578.33% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 10/14/2025 | 343 | $425 | 100.00% | 0.00% |
| MURPHY & MULLICK CAPITAL MANAGEMENT CORP | 11/07/2025 | 160 | $251 | 0.00% | 0.00% |
| PRINCETON GLOBAL ASSET MANAGEMENT LLC | 10/09/2025 | 160 | $198 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 120 | $149 | 0.00% | 0.00% |
| SMALLWOOD WEALTH INVESTMENT MANAGEMENT, LLC | 10/17/2025 | 120 | $148 | 0.00% | 0.00% |
| QUENT CAPITAL, LLC | 10/27/2025 | 108 | $134 | 100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 107 | $133 | 0.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 11/14/2025 | 84 | $104 | 100.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 11/14/2025 | 80 | $99 | 0.00% | 0.00% |
| FAIRSCALE CAPITAL, LLC | 11/06/2025 | 42 | $52 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 40 | $50 | 100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
| HEIGHTS CAPITAL MANAGEMENT, INC | 11/18/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| LARSON FINANCIAL GROUP LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BAY COLONY ADVISORY GROUP, INC D/B/A BAY COLONY ADVISORS | 10/24/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Citius Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 51 institutional investors and hedge funds held shares of Citius Pharmaceuticals, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 166,390
GEODE CAPITAL MANAGEMENT, LLC: 119,771
BlackRock, Inc.: 69,851
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 48,186
NORTHERN TRUST CORP: 27,025
UBS Group AG: 25,913
5.67% of Citius Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.83 M shares in the last 24 months. This purchase volume represents approximately $3.88 M in transactions.